drugset / Trial / NCT06782139
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Phase 4
Recruiting
30 enrolled
Korea University Anam Hospital
Daewoong Pharmaceutical Co. LTD. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study is to analyze the effects of enavogliflozin on heart function and coronary microvascular function in obese patients compared to a placebo, and to evaluate the improvement in cardiopulmonary exercise capacity in these patients.
Timeline
- Start
- 2025-01-20
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enavogliflozin | Small molecule | 0.3 mg | — |